ETF Holdings Breakdown of EYPT

Stock Name	Eyepoint Pharmaceuticals Inc
Ticker	EYPT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US30233G2093
LEI	549300QE1RU34T50MR69

News associated with EYPT

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shares Sold by Renaissance Technologies LLC: Renaissance Technologies LLC reduced its position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 26.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 137,500 shares of the company’s stock after selling 49,937 shares during the period. Renaissance Technologies LLC’s holdings in […] - 2025-05-01 08:31:09
Legal & General Group Plc Boosts Stock Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT): Legal & General Group Plc grew its position in shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 4.4% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 46,263 shares of the company’s stock after purchasing an additional 1,932 shares during the period. Legal & General Group Plc’s holdings in EyePoint Pharmaceuticals were […] - 2025-05-01 07:45:01
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives $26.63 Average Target Price from Analysts: EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received a consensus rating of “Buy” from the nine ratings firms that are presently covering the stock, MarketBeat reports. Nine analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock in […] - 2025-04-25 05:52:46
Wellington Management Group LLP Acquires 5,552 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT): Wellington Management Group LLP lifted its holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 3.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 177,316 shares of the company’s stock after buying an additional 5,552 shares during the period. Wellington Management Group LLP’s holdings in EyePoint Pharmaceuticals were worth $1,321,000 at the […] - 2025-04-14 07:50:52
Brokerages Set EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) PT at $26.63: EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are currently covering the firm, MarketBeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have issued a report on the stock […] - 2025-03-31 05:46:59
Intech Investment Management LLC Acquires 6,137 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT): Intech Investment Management LLC boosted its holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 36.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 23,105 shares of the company’s stock after buying an additional 6,137 shares during the quarter. Intech Investment Management […] - 2025-03-28 08:30:47
China Universal Asset Management Co. Ltd. Has $108,000 Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT): China Universal Asset Management Co. Ltd. grew its stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) by 40.6% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,472 shares of the company’s stock after buying an additional 4,179 shares during the quarter. China Universal […] - 2025-02-04 09:14:53

EYPT institutional holdings

The following institutional investment holdings of EYPT have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 39,401 USD 240,346 0.2%

2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 60,377 USD 368,300 0.2%

2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 34,494 USD 210,413

2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 34,494 USD 210,413 0.2%

2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,673 USD 10,205 0.2%

Total = 170,439 USD 1,039,677
Book value of shares is calculated on the adjusted close price of each day (row).

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	39,401	USD 240,346 0.2%
2025-05-08	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	60,377	USD 368,300 0.2%
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	34,494	USD 210,413
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	34,494	USD 210,413 0.2%
2025-05-08	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	1,673	USD 10,205 0.2%
Total =	170,439	USD 1,039,677

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.